Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education

BackgroundPhysicians often do not initiate or intensify treatments when clearly warranted, a phenomenon known as therapeutic inertia (TI). Limited information is available on educational interventions to ameliorate knowledge-to-action gaps in TI.ObjectivesTo evaluate the feasibility and efficacy of...

Full description

Bibliographic Details
Main Authors: Gustavo Saposnik, Jorge Maurino, Angel P. Sempere, Maria A. Terzaghi, Christian C. Ruff, Muhammad Mamdani, Philippe N. Tobler, Xavier Montalban
Format: Article
Language:English
Published: Frontiers Media S.A. 2017-08-01
Series:Frontiers in Neurology
Subjects:
Online Access:http://journal.frontiersin.org/article/10.3389/fneur.2017.00430/full
id doaj-7cf147b7c0934388882c700e0be8e51b
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Gustavo Saposnik
Gustavo Saposnik
Gustavo Saposnik
Jorge Maurino
Angel P. Sempere
Maria A. Terzaghi
Maria A. Terzaghi
Christian C. Ruff
Muhammad Mamdani
Philippe N. Tobler
Xavier Montalban
Xavier Montalban
spellingShingle Gustavo Saposnik
Gustavo Saposnik
Gustavo Saposnik
Jorge Maurino
Angel P. Sempere
Maria A. Terzaghi
Maria A. Terzaghi
Christian C. Ruff
Muhammad Mamdani
Philippe N. Tobler
Xavier Montalban
Xavier Montalban
Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education
Frontiers in Neurology
multiple sclerosis
disease-modifying therapy
neuroeconomics
decision making
risk aversion
author_facet Gustavo Saposnik
Gustavo Saposnik
Gustavo Saposnik
Jorge Maurino
Angel P. Sempere
Maria A. Terzaghi
Maria A. Terzaghi
Christian C. Ruff
Muhammad Mamdani
Philippe N. Tobler
Xavier Montalban
Xavier Montalban
author_sort Gustavo Saposnik
title Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education
title_short Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education
title_full Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education
title_fullStr Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education
title_full_unstemmed Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical Education
title_sort overcoming therapeutic inertia in multiple sclerosis care: a pilot randomized trial applying the traffic light system in medical education
publisher Frontiers Media S.A.
series Frontiers in Neurology
issn 1664-2295
publishDate 2017-08-01
description BackgroundPhysicians often do not initiate or intensify treatments when clearly warranted, a phenomenon known as therapeutic inertia (TI). Limited information is available on educational interventions to ameliorate knowledge-to-action gaps in TI.ObjectivesTo evaluate the feasibility and efficacy of an educational intervention compared to usual care among practicing neurologists caring for patients with multiple sclerosis (MS).MethodsWe conducted a pilot double-blind, parallel-group, randomized clinical trial. Inclusion criteria included neurologists who are actively involved in managing MS patients. Participants were exposed to 20 simulated case-scenarios (10 cases at baseline, and 10 cases post-randomization to usual care vs. educational intervention) of relapsing–remitting MS with moderate or high risk of disease progression. The educational intervention employed a traffic light system (TLS) to facilitate decisions, allowing participants to easily recognize high-risk scenarios requiring treatment escalation. We also measured differences between blocks to invoke decision fatigue. The control group responded as they would do in their usual clinical practice not exposed to the educational intervention. The primary feasibility outcome was the proportion of participants who completed the study and the proportion of participants who correctly identified a high-risk case-scenario with the “red traffic light.” Secondary outcomes included decision fatigue (defined as an increment of TI in the second block of case-scenarios compared to the first block) and the efficacy of the educational intervention measured as a reduction in TI for MS treatment.ResultsOf 30 neurologists invited to be part of the study, the participation rate was 83.3% (n = 25). Of the 25 participants, 14 were randomly assigned to the control group and 11 to the intervention group. TI was present in 72.0% of participants in at least one case scenario. For the primary feasibility outcome, the completion rate of the study was 100% (25/25 participants). Overall, 77.4% of participants correctly identified the “red traffic light” for clinical-scenarios with high risk of disease progression. Similarly, 86.4% of participants correctly identified the “yellow traffic light” for cases that would require a reassessment within 6–12 months. For the secondary fatigue outcome, within-group analysis showed a significant increased prevalence of TI in the second block of case-scenarios (decision fatigue) among participants randomized to the control group (TI pre-intervention 57.1% vs. TI post-intervention 71.4%; p = 0.015), but not in the active group (TI pre-intervention 54.6% vs. TI post-intervention 63.6%; p = 0.14). For the efficacy outcome, we found a non-significant reduction in TI for the targeted intervention compared to controls (22.6 vs. 33.9% post-intervention; OR 0.57; 95% CI 0.26–1.22).ConclusionAn educational intervention applying the TLS is feasible and shows some promising results in the identification of high-risk scenarios to reduce decision fatigue and TI. Larger studies are needed to determine the efficacy of the proposed educational intervention.Clinical Trial Registrationwww.ClinicalTrials.gov, identifier NCT03134794.
topic multiple sclerosis
disease-modifying therapy
neuroeconomics
decision making
risk aversion
url http://journal.frontiersin.org/article/10.3389/fneur.2017.00430/full
work_keys_str_mv AT gustavosaposnik overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT gustavosaposnik overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT gustavosaposnik overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT jorgemaurino overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT angelpsempere overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT mariaaterzaghi overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT mariaaterzaghi overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT christiancruff overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT muhammadmamdani overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT philippentobler overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT xaviermontalban overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
AT xaviermontalban overcomingtherapeuticinertiainmultiplesclerosiscareapilotrandomizedtrialapplyingthetrafficlightsysteminmedicaleducation
_version_ 1725424403042271232
spelling doaj-7cf147b7c0934388882c700e0be8e51b2020-11-25T00:05:35ZengFrontiers Media S.A.Frontiers in Neurology1664-22952017-08-01810.3389/fneur.2017.00430293227Overcoming Therapeutic Inertia in Multiple Sclerosis Care: A Pilot Randomized Trial Applying the Traffic Light System in Medical EducationGustavo Saposnik0Gustavo Saposnik1Gustavo Saposnik2Jorge Maurino3Angel P. Sempere4Maria A. Terzaghi5Maria A. Terzaghi6Christian C. Ruff7Muhammad Mamdani8Philippe N. Tobler9Xavier Montalban10Xavier Montalban11Division of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, CanadaLaboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, SwitzerlandOutcomes Research and Decision Neuroscience Unit, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, ON, CanadaNeuroscience Area, Medical Department, Roche Farma, Madrid, SpainDepartment of Neurology, Hospital General Universitario de Alicante, Alicante, SpainDivision of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, CanadaOutcomes Research and Decision Neuroscience Unit, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, ON, CanadaLaboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, SwitzerlandHealthcare Analytics Research, Li Ka Shing Knowledge Institute, St. Michael’s Hospital, University of Toronto, Toronto, ON, CanadaLaboratory for Social and Neural Systems Research, Department of Economics, University of Zurich, Zurich, SwitzerlandDivision of Neurology, Department of Medicine, St. Michael’s Hospital, University of Toronto, Toronto, ON, CanadaNeurology-Neuroimmunology Department, Neurorehabilitation Unit, Multiple Sclerosis Centre of Catalonia (Cemcat), Barcelona, SpainBackgroundPhysicians often do not initiate or intensify treatments when clearly warranted, a phenomenon known as therapeutic inertia (TI). Limited information is available on educational interventions to ameliorate knowledge-to-action gaps in TI.ObjectivesTo evaluate the feasibility and efficacy of an educational intervention compared to usual care among practicing neurologists caring for patients with multiple sclerosis (MS).MethodsWe conducted a pilot double-blind, parallel-group, randomized clinical trial. Inclusion criteria included neurologists who are actively involved in managing MS patients. Participants were exposed to 20 simulated case-scenarios (10 cases at baseline, and 10 cases post-randomization to usual care vs. educational intervention) of relapsing–remitting MS with moderate or high risk of disease progression. The educational intervention employed a traffic light system (TLS) to facilitate decisions, allowing participants to easily recognize high-risk scenarios requiring treatment escalation. We also measured differences between blocks to invoke decision fatigue. The control group responded as they would do in their usual clinical practice not exposed to the educational intervention. The primary feasibility outcome was the proportion of participants who completed the study and the proportion of participants who correctly identified a high-risk case-scenario with the “red traffic light.” Secondary outcomes included decision fatigue (defined as an increment of TI in the second block of case-scenarios compared to the first block) and the efficacy of the educational intervention measured as a reduction in TI for MS treatment.ResultsOf 30 neurologists invited to be part of the study, the participation rate was 83.3% (n = 25). Of the 25 participants, 14 were randomly assigned to the control group and 11 to the intervention group. TI was present in 72.0% of participants in at least one case scenario. For the primary feasibility outcome, the completion rate of the study was 100% (25/25 participants). Overall, 77.4% of participants correctly identified the “red traffic light” for clinical-scenarios with high risk of disease progression. Similarly, 86.4% of participants correctly identified the “yellow traffic light” for cases that would require a reassessment within 6–12 months. For the secondary fatigue outcome, within-group analysis showed a significant increased prevalence of TI in the second block of case-scenarios (decision fatigue) among participants randomized to the control group (TI pre-intervention 57.1% vs. TI post-intervention 71.4%; p = 0.015), but not in the active group (TI pre-intervention 54.6% vs. TI post-intervention 63.6%; p = 0.14). For the efficacy outcome, we found a non-significant reduction in TI for the targeted intervention compared to controls (22.6 vs. 33.9% post-intervention; OR 0.57; 95% CI 0.26–1.22).ConclusionAn educational intervention applying the TLS is feasible and shows some promising results in the identification of high-risk scenarios to reduce decision fatigue and TI. Larger studies are needed to determine the efficacy of the proposed educational intervention.Clinical Trial Registrationwww.ClinicalTrials.gov, identifier NCT03134794.http://journal.frontiersin.org/article/10.3389/fneur.2017.00430/fullmultiple sclerosisdisease-modifying therapyneuroeconomicsdecision makingrisk aversion